Vaccine provides protection against five diseases

Infanrix-IPV+Hib is a multi-component vaccine that provides protection against diphtheria, tetanus, pertussis, polio and invasive diseases caused by Haemophilus influenzae type b.

Infanrix-IPV+Hib is appropriate for the active immunisation of children from age two months.

Primary immunisation is a course of two or three doses, separated by a minimum of four weeks between each dose. A booster dose should be given at least six months after the last priming dose, preferably between 11 and 13 months of age. The vaccine is not suitable for children over 36 months of age.

Further information: GlaxoSmithKline, Stockley Park West, Uxbridge, Middlesex UB1 1BT. Tel: (0800) 221441.
Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

New products - live tracker

New products - live tracker

EXCLUSIVE TO SUBSCRIBERS See the latest products added...

Drug price changes - live tracker

Drug price changes - live tracker

EXCLUSIVE TO SUBSCRIBERS Use our constantly updated...

Direct-acting oral anticoagulants set for wider use under NHS deal

Direct-acting oral anticoagulants set for wider use under NHS deal

More than half a million more people will be able to...

NICE recommends SGLT2 inhibitors for chronic kidney disease

NICE recommends SGLT2 inhibitors for chronic kidney disease

Updated NICE guidance on type II diabetes recommends...